-
Stock prices plummet, and Fate will cut 60% of its workforce and cut multiple CAR-NK clinical programs
Time of Update: 2023-02-01
Since 2019, a number of iPSC-based CAR-T and car-NK cell therapies have entered clinical trials, and Fate's market value once exceeded ten billion US dollars.
Since 2019, a number of iPSC-based CAR-T and car-NK cell therapies have entered clinical trials, and Fate's market value once exceeded ten billion US dollars.
-
This in vitro diagnostic company handed over its first "transcript" after its listing on the Science and Technology Innovation Board, with frequent highlights
Time of Update: 2022-05-18
The annual report released by Reon Gene on the evening of April 19 shows that in 2021, the company will achieve operating income of 291 million yuan, a year-on-year increase of 2.
-
Abandoning U.S. stocks and going to Hong Kong stocks, what benefits might it have for Freshwind Medical, the parent company of United Family Hospital
Time of Update: 2021-07-25
Reporter | Jin MiaoEdit|Xu Yue On the eve of the Spring Festival of the Year of the Ox, New Frontier Medical, the parent company of United Family Hospital, issued an announcement that the company’s board of directors received a non-binding privatization offer issued by a consortium of buyers including New Frontier Public Holding Limited on February 9, 2021.
-
Wuxi apptec's "one dismantling and three dismantling" successfully completed the total market value or exceeded 150 billion yuan
Time of Update: 2018-03-28
Source: on March 28, 2018, after Foxconn's 36 day "lightning" meeting record, another medical "unicorn" worthy of attention will be launched According to insiders, on March 27, at the 51st working mee
